Friday 21 September 2018
Contact US    |    Archive
Reuters
2 months ago

CORRECTED-FOCUS-Eisai/Biogen to advance Alzheimer s drug, provide fresh hope

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer’s disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

CORRECTED

 | 

FOCUS

 | 

Eisai

 | 

Biogen

 | 

advance

 | 

Alzheimer

 | 

drug

 | 

provide

 | 

fresh

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)